Welcome to Markets Desk, your midday read on what's moving markets and policy.
The Federal Reserve may be quietly entering a new era. Kevin Warsh has begun restructuring the institution from the inside, establishing task forces to rethink core Fed functions across the board. Analysts are calling it a velvet revolution — methodical, deliberate, and with potentially sweeping consequences for how monetary policy gets made in the years ahead.
Shifting to the auto sector, Ford and General Motors are making a serious pivot into energy storage, and the market is paying attention. Ford's newly announced energy business has drawn genuine investor enthusiasm, signaling that legacy automakers aren't just chasing electric vehicles — they're repositioning themselves as broader energy infrastructure plays, which fundamentally changes how you value these names.
And in the pharmaceutical space, the next front in the weight loss drug race is muscle preservation. Nearly every major drugmaker is now developing molecules designed to prevent lean mass loss during weight reduction — some mimic exercise at the cellular level, others block muscle breakdown pathways. With GLP-one drugs already reshaping healthcare spending, this next generation could expand the market considerably further.
That's the tape. Markets Desk, signing off the floor.
